Standard addition-guided correction of charcoal-stripped serum noncommutability in 13C isotope-dilution LC-MS/MS quantification of endogenous serum folates

Authors:

Abstract
Charcoal-stripped serum (CSS) is widely used as a surrogate blank matrix for LC-MS/MS quantification of endogenous serum analytes when true analyte-free serum is unavailable. However, the commutability of CSS with native serum is often assumed rather than experimentally verified. In this study, endogenous serum folate vitamers were used as a clinically relevant model system to evaluate whether CSS-based calibration remains commutable with native serum under 13C isotope-dilution LC-MS/MS conditions and to develop a practical correction approach when noncommutability is present. A rapid LC-MS/MS assay was developed for 5methyltetrahydrofolate (5-mTHF), folic acid (FA), and folinic acid. The assay achieved LODs of 0.009 ng/mL for 5-mTHF and folinic acid and 0.0375 ng/mL for FA, with LOQs of 0.059 ng/mL for 5-mTHF and folinic acid and 0.117 ng/mL for FA, linearity from 0.059 to 60 ng/mL (R2 > 0.995), recoveries of 93% to 96%, and intra-day and inter-day imprecision below 15%. Post-extraction spiking and pooled-serum standard addition showed analyte-dependent and batch-dependent noncommutability between CSS and native serum. Standard-addition slope comparison revealed matrix factors of 1.005 to 1.611 for 5-mTHF, 0.607 to 1.000 for FA, and 0.902 to 1.008 for folinic acid, corresponding to ion enhancement for 5-mTHF, ion suppression for FA, and minimal matrix bias for folinic acid. A pooled-serum, batch-specific matrix-factor correction reduced validation bias for 5-mTHF and FA to within the commonly accepted ±15% criterion. When applied to 66 pediatric clinical serum samples, matrix-factor correction changed classification relative to selected reference decision limits in 10 of 35 patients for 5-mTHF and 5 of 35 patients for FA. Exploratory LC-MS/MS analysis further indicated the presence of co-eluting lipid-related compounds in native serum extracts, supporting residual matrix composition as a plausible contributor to the observed bias. These findings demonstrate that CSS-based calibration can produce clinically relevant matrix-dependent bias in endogenous LC-MS/MS assays despite 13C internal-standard correction. Pooled-serum standard addition provides a regulatory-compatible and sample-sparing approach to quantify and correct this bias without requiring standard addition in every clinical specimen.